Study title:
Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty. Paterson WF, McNeill E, Young D, Donaldson MDC. Clinical Endocrinology 2004;61(5)(Suppl 2):626-34 2004;(5):626-634.Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty. Paterson WF, McNeill E, Young D, Donaldson MDC. Clinical Endocrinology 2004;61(5)(Suppl 2):626-34 2004;(5):626-634.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Endocrine System Diseases [C19]
|
Brands: Please see report, Please see report |
MAH holders: Please see report, Please see report |
Assessment: |
Active substance: GOSERELIN |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|